ENOVID Drug Patent Profile
✉ Email this page to a colleague
When do Enovid patents expire, and what generic alternatives are available?
Enovid is a drug marketed by Gd Searle Llc and is included in one NDA.
The generic ingredient in ENOVID is mestranol; norethynodrel. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethynodrel profile page.
Summary for ENOVID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ENOVID at DailyMed |
US Patents and Regulatory Information for ENOVID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL | 010976-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Gd Searle Llc | ENOVID-E | mestranol; norethynodrel | TABLET;ORAL-20 | 010976-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL | 010976-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |